Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Chimerix Inc (CMRX)

Chimerix Inc (CMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks Stocktwits - Fri Nov 22, 2:10PM CST

Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.

SIGA : 6.63 (-7.27%)
EBS : 9.48 (-3.66%)
GOVX : 2.41 (-4.74%)
CMRX : 0.8602 (-3.33%)
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting GlobeNewswire - Mon Nov 11, 6:00AM CST

CMRX : 0.8602 (-3.33%)
Chimerix: Q3 Earnings Snapshot AP - Thu Nov 7, 6:35AM CST

Chimerix: Q3 Earnings Snapshot

CMRX : 0.8602 (-3.33%)
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update GlobeNewswire - Thu Nov 7, 6:00AM CST

CMRX : 0.8602 (-3.33%)
Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024 GlobeNewswire - Fri Nov 1, 6:00AM CDT

CMRX : 0.8602 (-3.33%)
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Oct 18, 3:31PM CDT

CMRX : 0.8602 (-3.33%)
Chimerix: Q2 Earnings Snapshot AP - Tue Aug 13, 6:14AM CDT

Chimerix: Q2 Earnings Snapshot

CMRX : 0.8602 (-3.33%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market GlobeNewswire - Tue Aug 6, 7:45AM CDT

NNVC : 1.4100 (-0.70%)
VERU : 0.7199 (+3.61%)
CMRX : 0.8602 (-3.33%)
SIGA : 6.63 (-7.27%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market FinancialNewsMedia - Tue Aug 6, 7:45AM CDT

EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END

BCRX : 7.23 (-2.03%)
NNVC : 1.4100 (-0.70%)
VERU : 0.7199 (+3.61%)
CMRX : 0.8602 (-3.33%)
SIGA : 6.63 (-7.27%)
Chimerix: Q1 Earnings Snapshot AP - Wed May 1, 6:33AM CDT

Chimerix: Q1 Earnings Snapshot

CMRX : 0.8602 (-3.33%)

Barchart Exclusives

Insiders Are Buying This Potential M&A Target, Should You? Barchart - 58 minutes ago
This potential M&A target recently witnessed major insider activity from a number of individuals including the chair. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot